Next Article in Journal
The Bioavailability of Glycyrrhizinic Acid Was Enhanced by Probiotic Lactobacillus rhamnosus R0011 Supplementation in Liver Fibrosis Rats
Previous Article in Journal
Association between the Preoperative C-Reactive Protein-to-Albumin Ratio and the Risk for Postoperative Pancreatic Fistula following Distal Pancreatectomy for Pancreatic Cancer
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 14
Issue 24
10.3390/nu14245267
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Risk of Malnutrition in Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis

by
Xiaoru Feng
1,
Zeqi Liu
1,
Xiaotong He
2,
Xibiao Wang
3,
Changzheng Yuan
4,5,
Liyan Huang
4,
Rui Song
5 and
You Wu
1,6,*
1
Institute for Hospital Management, Tsinghua University, Beijing 100084, China
2
School of Labor and Human Resources, Renmin University of China, Beijing 100872, China
3
Department of Occupational Hygiene Engineering, China University of Labor Relations, Beijing 100048, China
4
School of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, China
5
Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA
6
School of Medicine, Tsinghua University, Beijing 100084, China
*
Author to whom correspondence should be addressed.
Nutrients 2022, 14(24), 5267; https://doi.org/10.3390/nu14245267
Submission received: 20 October 2022 / Revised: 26 November 2022 / Accepted: 7 December 2022 / Published: 10 December 2022
(This article belongs to the Section Nutritional Epidemiology)
Browse Figures
Review Reports Versions Notes

Abstract

:
(1) Background: Studies have reported that COVID-19 may increase the risk of malnutrition among patients. However, the prevalence of such risk in hospitalized COVID-19 patients is uncertain due to the inconsistent use of assessment methods. (2) Methods: PubMed, Web of Science, and EMBASE were searched to identify studies on the nutritional status of hospitalized COVID-19 patients. A pooled prevalence of malnutrition risk evaluated by Nutrition Risk Score (NRS-2002) was obtained using a random effects model. Differences by study-level characteristics were examined by hospitalization setting, time of assessment, age, and country. Risk of bias was assessed using the Newcastle–Ottawa Scale. (3) Results: 53 studies from 17 countries were identified and summarized. A total of 17 studies using NRS-2002, including 3614 COVID-19 patients were included in the primary meta-analysis. The pooled prevalence of risk of malnutrition was significantly higher among ICU patients (92.2%, 95% CI: 85.9% to 96.8%) than among general ward patients (70.7%, 95% CI: 56.4% to 83.2%) (p = 0.002). No significant differences were found between age groups (≥65 vs. <65 years, p = 0.306) and countries (p = 0.893). (4) Conclusions: High risk of malnutrition is common and concerning in hospitalized patients with COVID-19, suggesting that malnutrition screening and nutritional support during hospitalization are needed.

1. Introduction

The coronavirus disease 2019 (COVID-19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly spread across the globe. The impact of COVID-19 is multi-dimensional, closely intertwined with the nutritional status both at the individual and population level. Changes in eating behavior and lifestyle, due to quarantine and social isolation, may lead to an impaired nutritional status [1]. Meanwhile, numerous studies have shown that malnutrition impacts viral replication and pathogenicity [2], induces atrophy of primary lymphoid organs, reducing T-cell and B-cell numbers, leading to leukopenia [3,4], and thus can increase the risk of illness following infection with SARS-CoV-2 [5]. Researchers around the world have reported a series of complications and sequelae of COVID-19, including dyspnea [6,7,8], cough [9], pulmonary fibrosis [10], pulmonary embolism [11], strokes [12,13], central nervous system (CNS) damage [14], cardiac arrhythmias [15], olfactory and taste disorders [16], and psychiatric disorders [17,18]. However, since the physiological risk caused by malnutrition is not immediate, and the assessment and monitoring of nutritional status are highly demanding on professional assessors, the increased risk of malnutrition during COVID-19 pandemic has not been paid enough attention.
The inpatient population is at high risk for malnutrition. It has been observed that nearly all hospitalized patients, including those with COVID-19, have poor nutritional status upon admission [19,20]. Malnutrition in patients is accompanied by low levels of lymphocytes, prealbumin, and albumin [20], which are significantly associated with a higher risk of transfer to intensive care unit (ICU) [21], a declined immune response and increased risk of infections [22], prolonged hospitalization [23], and poor prognosis [24]. Conversely, patients with critical symptoms of COVID-19 are at higher risk of malnutrition. Symptoms, including anorexia, diarrhea, vomiting, nausea, and mild abdominal pain, have been reported in COVID-19 patients [25], while antiviral drugs may exacerbate gastrointestinal symptoms [26]. These may result in an imbalance in energy intake and expenditure.
Though studies have addressed the potential mechanisms and associations between malnutrition and COVID-19 [23,27,28], nutritional assessment has not been generally incorporated in the clinical routine or the official guidelines of COVID-19 care [29,30,31]. Characterizing malnourished patients with COVID-19 is crucial to the management of the diagnosis, treatment, and to patient care in general, yet there is limited research on the prevalence of malnutrition or risk of malnutrition among patients with COVID-19, based on different population settings. Therefore, this systematic review and meta-analysis was conducted to estimate the pooled prevalence of malnutrition risk in hospitalized patients with COVID-19, including stratification by types of hospitalization, time of assessment, age, and country.

2. Methods

This systematic review was performed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. The review protocol was registered with PROSPERO (CRD42022338383).

2.1. Search Strategy

We searched databases including PubMed, Web of Science, and EMBASE through 31 August 2022. To maximize the search for relevant articles, we also reviewed the reference lists of the relevant systematic reviews. The specific search strategy included combinations of the following MeSH and other key terms: “COVID-19”, “SARS-CoV-2”, “2019 Novel Coronavirus Disease”, “malnutrition”, “nutritional deficiency”, “nutritional status”. The search strategy is presented in Table S1.

2.2. Eligibility Criteria

Studies were included in the initial systematic review if they met the following criteria: (1) population: adult (age ≥ 18 years) patients with a confirmed diagnosis of COVID-19; (2) exposure: COVID-19 infection leading to hospitalization; (3) outcome: malnutrition or risk of malnutrition identified by validated assessment tools; and (4) study type: cohort studies and cross-sectional studies. In the full text review, studies were excluded if they did not report the prevalence of malnutrition or risk of malnutrition.

2.3. Study Selection

The two independent reviewers (X. F. and X. H.) first screened the titles and abstracts to identify potentially relevant studies. In the next step, the full texts were evaluated according to the inclusion and exclusion criteria. Disagreements were resolved by discussion and consensus with a third reviewer (Y. W.).

2.4. Quality Assessment

All included studies were checked for risk of bias by two independent reviewers (Z. L. and X. W.). In case of disagreements, a third reviewer was consulted for assistance (Y. W.). We used the Newcastle–Ottawa Scale for assessing the quality of studies in meta-analysis, with the evaluation dimensions adapted to cross-sectional studies and to our research question. The dimensions included selection (representativeness, description of non-respondents/excluded patients, and ascertainment of the exposure); comparability (control for important and additional factors); and outcome (the use and data collection of the assessment of tool, and the statistical parameter). Each dimension was assigned one point; a maximum of eight points could be granted if a study satisfied all requirements. In the sensitivity analysis, the results of all studies and the studies with ≥6 points were analyzed and compared.

2.5. Data Extraction

Two independent researchers (Y. W. and X. F.) extracted the following data from the included studies, and disagreements were resolved by consensus: (1) article information: the last name of the study’s first author and publication year; (2) study information: country, study design(cohort study or cross-sectional study), and time frame; (3) population information: age, sex, race/ethnicity, population size, population source (general ward patients or ICU patients), and severity of COVID-19; and (4) malnutrition information: timing of assessment (at admission or during hospitalization), assessment tool, and prevalence data. When there were both general ward patients and ICU patients in a study, they were considered separately.

2.6. Statistical Analysis

Since heterogeneity in malnutrition prevalence was expected across populations, we performed a random effects model to estimate the pooled prevalence of risk of malnutrition and the 95% confidence intervals. The prevalence data were pooled separately by each assessment method. To detect any difference between the settings of hospitalization and the timings of nutritional status assessment with enough power, we quantitatively synthesized studies using NRS-2002, as it was the most commonly used tool. NRS-2002 score ≥ 3 is considered at risk of malnutrition (NRS 3–4: moderate risk of malnutrition; NRS ≥ 5: severe risk of malnutrition). All analyses were performed for general ward patients and ICU patients separately.
We assessed between-study heterogeneity using Q statistic and the I2-test statistic. Furthermore, to identify additional possible sources of heterogeneity, subgroup analyses were performed according to the World Bank country classification by income level and the median or mean age (≥65 and <65 years) of the study population, respectively. Heterogeneity between groups were assessed by chi-squared test [32].
For meta-analysis of proportion data, studies have shown that the visual appearance of funnel plots and the sensitivity of Egger’s regression to detect asymmetry are prone to misclassification [33,34]. A Doi plot, instead, was proposed to find out any publication bias in pooled analysis of proportions, and the risk can be further quantified using the Luis Furuya-Kanamori (LFK) index [35]. An LFK index within ±1, out of ±1 but within ±2, and out of ±2 indicates no asymmetry, minor asymmetry, and major asymmetry, respectively.
All data were analyzed using Stata 15.0 (Stata Corporation, College Station, TX, USA) and MetaXL 5.3 (EpiGear International, Noosa, Queensland, Australia). We used the metaprop command in Stata as it allows inclusion of studies with proportions equal to zero or 100 percent and avoids confidence intervals beyond the 0 to 1 range. To stabilize the variance, all analyses adopted the Freeman–Tukey double arcsine transformation [32]. For all hypothesis tests, p < 0.05 was considered statistically significant.

3. Results

3.1. Search Results

The systematic literature search identified a total of 4429 articles in the three databases. After removing 954 duplicates, the titles and abstracts of 3475 articles were screened, of which 2588 were excluded due to inappropriate subject matter. The remaining publications were examined based on the inclusion and exclusion criteria. A total of 53 articles using various assessment tools (Body Mass Index [BMI], Controlling Nutritional Status Score [CONUT], Global Leadership Initiative on Malnutrition [GLIM], Geriatric Nutritional Risk Index [GNRI], Mini Nutritional Assessment [MNA], Modified Nutrition Risk in the Critically ill [mNUTRIC], Malnutrition Universal Screening Tool [MUST], Nutrition Risk Screening-2002 [NRS-2002], and Subjective Global Assessment [SGA]) are summarized in Table S2. Significant differences between the measurement tools (p < 0.001, Figures S1–S4) suggested that the prevalence measured by the above-mentioned instruments were not comparable. A total of 17 articles using NRS-2002 were included in the quantitative meta-analysis to compare the prevalence of malnutrition risk assessed at different time hospitalization settings and points. The flow diagram for the literature review and article selection process following the PRISMA guideline is shown in Figure 1.

3.2. Study Characteristics

Table S2 summarizes the 53 studies of interest by all assessment tool. Table 1 presents the characteristics of the studies using NRS-2002 [36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52]. These 17 studies included in the primary meta-analysis were from nine different countries. A total of 3614 COVID-19 patients were included in these studies with median/mean age ranging from 45.7 to 86.1 years. Regarding population sources, 13 studies recruited patients in the general wards and six studies recruited patients in ICUs.

3.3. Quality Assessment

The results of the quality assessment are shown in Figure 2. 15 out of 17 studies are ≥6 points. Most of the individual studies lost points because the protocols of data collection in the outcome assessment were not detailed (nine out of 17 studies). When analysis was limited to studies with six points and above, the pooled prevalence changed by less than 10% across groups.

3.4. Prevalence of Risk of Malnutrition among Hospitalized Patients with COVID-19

3.4.1. Overall Results

The pooled prevalence of malnutrition risk among patients with COVID-19 as assessed by NRS-2002 is shown in Figure 3. The pooled prevalence of ICU patients (92.2%, 95% CI: 85.9% to 96.8%) was significantly higher than that of general ward patients (70.7%, 95% CI: 56.4% to 83.2%) (p = 0.002). For general ward patients, there were not significant between-group differences for subgroup analysis by time of assessment for prevalence of risk of malnutrition (p = 0.083, Figure S5). Pooled prevalence of malnutrition or risk of malnutrition as assessed by other instruments ranged from 11.8–83.3% for general ward patients and 31.5–94.4% for ICU patients (Figures S1–S4).

3.4.2. Subgroup Analyses

To identify the prevalence of malnutrition risk in COVID-19 patients of different ages, 12 studies were grouped by median/mean age ≥65 vs. <65 years. Studies with median/mean age ≥ 65 years (80.5%, 95% CI: 64.0% to 92.9%) showed higher pooled prevalence of malnutrition risk than those with median/mean age <65 years (64.1%, 95% CI: 34.6 to 88.8%), although this was not statistically significant (p = 0.306) (Figure 4).
According to the World Bank criteria for classifying countries by income level, the individual studies were stratified into three categories: high-income economies (Switzerland, Spain, Italy, and Poland), upper-middle-income economies (China and Brazil), and lower-middle-income economies (Philippines, Egypt, and Iran). The pooled prevalence in the high-income economies, upper-middle-income economies, and lower-middle-income economies was 78.9% (95% CI: 65.0% to 90.0%), 81.5% (95% CI: 70.3% to 90.5%), and 73.6% (95% CI: 35.0% to 98.2%), respectively, indicating little difference between countries by income level (p = 0.893) (Figure 5).

3.5. Publication Bias

Risk of bias assessment for all studies and two subgroups were visualized by Doi plots (Figure S6). Only minor asymmetry was found for general ward patients (LFK = −1.91), whereas no evidence of publication bias was found in the case of all studies (LFK = −0.83) and the studies of ICU patients (LFK = 0.97).

4. Discussion

Hospitalized patients are a high-risk group for malnutrition [53]. Malnutrition can result in some adverse consequences, including hypercatabolism, rapid muscle wasting [54], weakened immune response [54], longer hospital length of stay [55], and higher hospital mortality [56]. The COVID-19 pandemic has brought about a spike in hospitalizations, calling for a closer monitoring of nutritional status in patient care.

4.1. Main Findings

In our study, we comprehensively summarized the prevalence of malnutrition and risk of malnutrition assessed by different tools and conducted a quantitative meta-analysis of the risk of malnutrition measured by NRS-2002, including 17 studies from nine countries with 3614 hospitalized COVID-19 patients from general wards and ICU. The pooled prevalence of malnutrition risk of general ward patients and ICU patients was 70.7% and 92.2%, respectively.
Our results are in line with other studies that suggested higher prevalence of malnutrition risk among hospitalized COVID-19 patients compared with hospitalized patients of other diseases [53,57]. Unlike previous qualitative reviews [24,53,58] on the nutritional status of COVID-19 patients, we conducted a quantitative meta-analysis to estimate the pooled prevalence of risk of malnutrition.
Risk of malnutrition was found more prevalent among ICU hospitalized COVID-19 patients than general ward patients, suggesting that malnutrition might be of a greater threat to COVID-19 patients with severe symptoms. Therefore, regular assessment of the nutritional status in hospitalized patients, especially in ICU patients, is highly recommended. We did not observe significant difference by income or age group, suggesting that malnutrition is a common phenomenon that should be treated equally across age groups and countries. Although the age subgroup analysis was not statistically significant, since the elderly population is inherently at higher risk of diabetes, low albumin, and vitamin D deficiency [28,59], the consequences of malnutrition risk could be more severe for them. We recommend that more attention be paid to this population.

4.2. Assessment Tools for Malnutrition and Risk of Malnutrition

Nutritional screening measures used in COVID-19 patients can be divided into three categories: (1) Traditional nutritional screening measures: NRS-2002, MNA, GLIM, mNUTRIC, and MUST; these tools have full nutritional assessment, and are applied by specialized professionals, such as nutritionists and doctors; (2) Calculated nutritional indices: PNI and COUNUT; they are based on one routine investigations and easy to calculate without a need for sophisticated skills; (3) Combinations of clinical characteristics, anthropometric measures, and nutritional biomarkers [60]. Among the most widely used tools, NRS-2002 score is a composition of nutritional score, disease severity score, and age-adjusted score, suitable for assessing the risk of malnutrition [61]; for rapid screening of hospitalized patients, NRS-2002 is considered a relatively mature instrument that has better feasibility and predictive validity for prolonged hospitalization [53]. For formal diagnosis of malnutrition, a more comprehensive GLIM evaluation is recommended [21,55].
In recent years, in order to obtain the nutritional status of hospitalized patients in real time, some information technologies have been used for nutritional monitoring of hospitalized patients. One study developed a tablet app as a tool to monitor dietary intake in hospitalized patients at nutritional risk [62]. Another study used a new clinical decision support system that combined collected clinical data with patient-generated data from a smartphone app to monitor patients’ nutritional status [63]. These digital tools and applications can reduce the workload and time spent on nutritional assessments for healthcare professionals.

4.3. Recommendations following Malnutrition Screening

In addition to early assessment of nutritional status and identification of nutritional risks through various screening tools, the nutritional status of COVID-19 patients can also be optimized by conducting nutritional counseling with professionals such as registered dietitians and clinical dietitians [64]. According to European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines, COVID-19 patients diagnosed with malnutrition should receive adequate vitamin and mineral supplementation, including vitamins A, B, C, D, omega-3 polyunsaturated fatty acids and micronutrients such as selenium, zinc and iron [64]. Patients diagnosed with moderate malnutrition should take oral nutritional supplements (ONS) in addition to dietary multivitamins and micronutrients. For severely malnourished patients, enteral nutrition (EN) or ONS should be provided if respiratory status contraindicates EN [53]. Besides, regular physical activities are encouraged to maintain physical and mental health as well as muscle mass and body composition.
For general ward inpatients, ESPEN encourages oral feeding rather than EN or parenteral nutrition (PN) unless contraindicated [64]. A variety of high-calorie diets as well as easily digestible foods and snacks can be offered to COVID-19 patients to increase protein-calorie intake, such as yogurt, mousse, cheese, etc. For patients with eating difficulties, ONS and intravenous multivitamins, multiminerals, and trace element solutions are options available [65].
For patients in ICU, although oral is the preferred feeding route, EN or PN are recommended immediately after ICU admission when contraindications are present. ESPEN recommends feeding within 48 h of ICU admission for COVID-19 ICU patients [64], while American Society for Parenteral and Enteral Nutrition (ASPEN)/Society of Critical Care Medicine (SCCM) believes EN should be provided within 24–36 h of ICU admission or within 12 h of intubation and placement on mechanical ventilation [66]. Because of the complex nutritional status of critically ill patients with COVID-19, all patients may require individualized diet-led nutritional interventions during their ICU stay [67].
Our study found that older populations tended to have a higher risk of malnutrition, although not significantly. Elderly COVID-19 patients are prone to high nutritional risk due to higher prevalence of comorbidities, aging-related changes in body composition, and decreased muscle mass [68]. ESPEN guidance for elderly patients with COVID-19 recommends that nutrition therapy should be started as early as possible after admission (within 24–48 h). For elderly patients whose nutritional status may have been compromised, nutritional therapy should be introduced gradually to prevent refeeding syndrome. In addition, evidence suggested that oral nutritional supplements (ONS) might have a slightly positive effect on energy intake, protein intake and mobility [69], and EN should be administered while potential complications is being monitored. Also, PN should be considered when EN fails to achieve the target [64].
To our knowledge, this is the first study to quantify the synthesize prevalence of malnutrition risk in COVID-19 patients. Based on our inclusion/exclusion criteria, all studies included (1) have good representativeness of the adult COVID-19 patient population; (2) used validated instruments for nutritional assessment (NRS-2002); and (3) presented detailed subgroup prevalence of risk of malnutrition in hospitalized patients with COVID-19. This allowed us to analyze subsets of the studies that have presented subgroup data for different stratification factors. All of these made our results more reliable and credible.
Our study has limitations as well. In quality assessment, we found that a few studies had relatively unsatisfactory reporting of the specific use of the NRS-2002 instrument and the details of the non-respondents. However, the sensitivity analysis including only the high-quality studies suggested little influence by such concerns. We recommend that future studies provide the protocol of data collection and any adaptation of the validated tools to the study population. Meanwhile, future studies may report number/proportion of patients excluded due to particular reasons, so that the representativeness of the study population could be justified. In the clinical settings of the included studies, the nutritional status of all patients before COVID-19 diagnosis was unknown. Therefore, the risk of malnutrition could not be considered as a consequence of COVID-19, but rather an observable variable that requires more attention, especially for those hospitalized in ICU. Although NRS-2002 is the most commonly used tool to assess risk of malnutrition, it was not routinely done in several major countries such as US, Australia, and Canada, where MUST, MST, mNUTRIC were used more often. Finally, we were not able to analyze the differences between different COVID-19 waves due to restriction by the time frame and the information available in the included studies. In future research, a comparative analysis on different COVID-19 waves, such as Alpha, Beta, Gamma, Delta, and Omicron periods would add new insights to the research topic.

5. Conclusions

Our results indicated that high risk of malnutrition is a common and concerning phenomenon in hospitalized patients with COVID-19, which highlights the importance of monitoring malnutrition and providing nutritional support during hospitalization. Risk of malnutrition is prevalent in all hospitalized COVID-19 patients regardless of the countries of origin, and the elderly remain a group deserving particular attention in inpatient care.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/nu14245267/s1, Table S1: Search Strategy; Table S2: Study characteristics by other malnutrition or risk of malnutrition assessment tools; Figure S1: Meta-Analysis of the Prevalence of Malnutrition or Risk of Malnutrition in COVID-19 Patients (General ward-at admission) by different assessment tools; Figure S2: Meta-Analysis of the Prevalence of Malnutrition or Risk of Malnutrition in COVID-19 Patients (General ward-during hospitalization) by different assessment tools; Figure S3: Meta-Analysis of the Prevalence of Malnutrition or Risk of Malnutrition in COVID-19 Patients (ICU-at admission) by different assessment tools; Figure S4: Meta-Analysis of the Prevalence of Malnutrition or Risk of Malnutrition in COVID-19 Patients (ICU-during hospitalization) by different assessment tools; Figure S5: Meta-Analysis of the Prevalence of Malnutrition or Risk of Malnutrition in COVID-19 Patients (General ward-at admission vs. General ward-during hospitalization) by Nutritional Risk Score-2002; Figure S6: Doi plot assessing publication bias of included studies. References [21,23,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,55,56,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100] are cited in the supplementary materials.

Author Contributions

Conceptualization, Y.W.; methodology, Y.W.; software, X.F. and Z.L.; validation, X.F. and X.H.; formal analysis, X.F. and Z.L.; data curation, X.F., X.H. and X.W.; writing—original draft preparation, X.F. and Z.L.; writing—review and editing, Y.W., L.H., C.Y. and R.S.; visualization, X.F., Z.L. and X.W.; supervision, Y.W.; All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data used for the analysis are available from the corresponding authors on request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Demasi, M. COVID-19 and Metabolic Syndrome: Could Diet Be the Key? Royal Society of Medicine: London, UK, 2021; Volume 26, pp. 1–2. [Google Scholar]
  2. Beck, M.A.; Handy, J.; Levander, O.A. Host nutritional status: The neglected virulence factor. Trends Microbiol. 2004, 12, 417–423. [Google Scholar] [CrossRef]
  3. Savino, W.; Dardenne, M.; Velloso, L.A.; Silva-Barbosa, S.D. The thymus is a common target in malnutrition and infection. Br. J. Nutr. 2007, 98, S11–S16. [Google Scholar] [CrossRef] [Green Version]
  4. Taylor, A.K.; Cao, W.; Vora, K.P.; Cruz, J.D.L.; Shieh, W.-J.; Zaki, S.R.; Katz, J.M.; Sambhara, S.; Gangappa, S. Protein Energy Malnutrition Decreases Immunity and Increases Susceptibility to Influenza Infection in Mice. J. Infect. Dis. 2012, 207, 501–510. [Google Scholar] [CrossRef] [Green Version]
  5. Skrajnowska, D.; Brumer, M.; Kankowska, S.; Matysek, M.; Miazio, N.; Bobrowska-Korczak, B. COVID-19: Diet Composition and Health. Nutrients 2021, 13, 2980. [Google Scholar] [CrossRef]
  6. Carfì, A.; Bernabei, R.; Landi, F. Persistent symptoms in patients after acute COVID-19. JAMA 2020, 324, 603–605. [Google Scholar] [CrossRef]
  7. Chopra, V.; Flanders, S.A.; O’Malley, M.; Malani, A.N.; Prescott, H.C. Sixty-day outcomes among patients hospitalized with COVID-19. Ann. Intern. Med. 2021, 174, 576–578. [Google Scholar] [CrossRef]
  8. Hu, B.; Guo, H.; Zhou, P.; Shi, Z.-L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2021, 19, 141–154. [Google Scholar] [CrossRef]
  9. Van Kampen, J.J.A.; Van De Vijver, D.A.M.C.; Fraaij, P.L.A.; Haagmans, B.L.; Lamers, M.M.; Okba, N.; van den Akker, J.P.C.; Endeman, H.; Gommers, D.A.M.P.J.; Cornelissen, J.J.; et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat. Commun. 2021, 12, 267. [Google Scholar] [CrossRef]
  10. Hosey, M.M.; Needham, D.M. Survivorship after COVID-19 ICU stay. Nat. Rev. Dis. Prim. 2020, 6, 60. [Google Scholar] [CrossRef]
  11. Lescure, F.-X.; Bouadma, L.; Nguyen, D.; Parisey, M.; Wicky, P.-H.; Behillil, S.; Gaymard, A.; Bouscambert-Duchamp, M.; Donati, F.; Le Hingrat, Q.; et al. Clinical and virological data of the first cases of COVID-19 in Europe: A case series. Lancet Infect. Dis. 2020, 20, 697–706. [Google Scholar] [CrossRef]
  12. Chen, J.; Wu, B.; Liu, F.; Jiao, G.; Lu, R.; Li, H.; Zhao, J.; Yang, Y.; Lu, X.; Li, J.; et al. Lung transplantation for an ARDS patient post-COVID-19 infection. Chest 2020, 157, A453. [Google Scholar] [CrossRef]
  13. George, P.M.; Wells, A.U.; Jenkins, R.G. Pulmonary fibrosis and COVID-19: The potential role for antifibrotic therapy. Lancet Respir. Med. 2020, 8, 807–815. [Google Scholar] [CrossRef]
  14. Ramlall, V.; Thangaraj, P.M.; Meydan, C.; Foox, J.; Butler, D.; Kim, J.; May, B.; De Freitas, J.K.; Glicksberg, B.S.; Mason, C.E. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection. Nat. Med. 2020, 26, 1609–1615. [Google Scholar] [CrossRef]
  15. Nougier, C.; Benoit, R.; Simon, M.; Desmurs-Clavel, H.; Marcotte, G.; Argaud, L.; David, J.S.; Bonnet, A.; Negrier, C.; Dargaud, Y. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-CoV2 associated thrombosis. J. Thromb. Haemost. 2020, 18, 2215–2219. [Google Scholar] [CrossRef]
  16. Puntmann, V.O.; Carerj, M.L.; Wieters, I.; Fahim, M.; Arendt, C.; Hoffmann, J.; Shchendrygina, A.; Escher, F.; Vasa-Nicotera, M.; Zeiher, A.M.; et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020, 5, 1265–1273. [Google Scholar] [CrossRef]
  17. Bai, C.; Chotirmall, S.H.; Rello, J.; Alba, G.A.; Ginns, L.C.; Krishnan, J.A.; Rogers, R.; Bendstrup, E.; Burgel, P.-R.; Chalmers, J.D.; et al. Updated guidance on the management of COVID-19: From an American Thoracic Society/European Respiratory Society coordinated international task force (29 July 2020). Eur. Respir. Rev. 2020, 29, 200287. [Google Scholar] [CrossRef]
  18. Luks, A.M.; Swenson, E.R. Pulse oximetry for monitoring patients with COVID-19 at home. Potential pitfalls and practical guidance. Ann. Am. Thorac. Soc. 2020, 17, 1040–1046. [Google Scholar] [CrossRef]
  19. Yeo, H.J.; Byun, K.S.; Han, J.; Kim, J.H.; Lee, S.E.; Yoon, S.H.; Jeon, D.; Kim, Y.S.; Cho, W.H. Prognostic significance of malnutrition for long-term mortality in community-acquired pneumonia: A propensity score matched analysis. Korean J. Intern. Med. 2019, 34, 841. [Google Scholar] [CrossRef]
  20. Laviano, A.; Koverech, A.; Zanetti, M. Nutrition support in the time of SARS-CoV-2 (COVID-19). Nutrition 2020, 74, 110834. [Google Scholar] [CrossRef]
  21. Bedock, D.; Lassen, P.B.; Mathian, A.; Moreau, P.; Couffignal, J.; Ciangura, C.; Poitou-Bernert, C.; Jeannin, A.-C.; Mosbah, H.; Fadlallah, J.; et al. Prevalence and severity of malnutrition in hospitalized COVID-19 patients. Clin. Nutr. ESPEN 2020, 40, 214–219. [Google Scholar] [CrossRef]
  22. Browne, N.T.; Snethen, J.A.; Greenberg, C.S.; Frenn, M.; Kilanowski, J.F.; Gance-Cleveland, B.; Burke, P.J.; Lewandowski, L. When Pandemics Collide: The Impact of COVID-19 on Childhood Obesity. J Pediatr Nurs 2021, 56, 90–98. [Google Scholar] [CrossRef]
  23. Yu, Y.; Ye, J.; Chen, M.; Jiang, C.; Lin, W.; Lu, Y.; Ye, H.; Li, Y.; Wang, Y.; Liao, Q.; et al. Malnutrition prolongs the hospitalization of patients with COVID-19 infection: A clinical epidemiological analysis. J. Nutr. Health Aging 2021, 25, 369–373. [Google Scholar] [CrossRef]
  24. Spolidoro, G.C.; Azzolino, D.; Shamir, R.; Cesari, M.; Agostoni, C. Joint effort towards preventing nutritional deficiencies at the extremes of life during COVID-19. Nutrients 2021, 13, 1616. [Google Scholar] [CrossRef]
  25. Guan, W.J.; Ni, Z.Y.; Hu, Y.; Liang, W.H.; Qu, C.Q.; He, J.X.; Liu, L.; Shan, H.; Lei, C.L.; Hui, D.S.C.; et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020, 382, 1708–1720. [Google Scholar] [CrossRef]
  26. Stachowska, E.; Folwarski, M.; Jamioł-Milc, D.; Maciejewska, D.; Skonieczna-Żydecka, K. Nutritional support in coronavirus 2019 disease. Medicina 2020, 56, 289. [Google Scholar] [CrossRef]
  27. Kurtz, A.; Grant, K.; Marano, R.; Arrieta, A.; Feaster, W.; Steele, C.; Ehwerhemuepha, L. Long-term effects of malnutrition on severity of COVID-19. Sci. Rep. 2021, 11, 14974. [Google Scholar] [CrossRef]
  28. Li, T.; Zhang, Y.; Gong, C.; Wang, J.; Liu, B.; Shi, L.; Duan, J. Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China. Eur. J. Clin. Nutr. 2020, 74, 871–875. [Google Scholar] [CrossRef] [Green Version]
  29. National Health Commission. National Administration of Traditional Chinese Medicine on March 15. Diagnosis and treatment protocol for COVID-19 patients (Trial Version 9). Health Care Sci. 2022, 1, 14–28. [Google Scholar] [CrossRef]
  30. National Institutes of Health. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Available online: https://www.covid19treatmentguidelines.nih.gov/ (accessed on 18 October 2022).
  31. Agarwal, A.; Rochwerg, B.; Lamontagne, F.; Siemieniuk, R.A.; Agoritsas, T.; Askie, L.; Lytvyn, L.; Leo, Y.-S.; Macdonald, H.; Zeng, L. A living WHO guideline on drugs for COVID-19. BMJ 2020, 370, m3379. [Google Scholar] [CrossRef]
  32. Nyaga, V.N.; Arbyn, M.; Aerts, M. Metaprop: A Stata command to perform meta-analysis of binomial data. Arch. Public Health 2014, 72, 39. [Google Scholar] [CrossRef]
  33. Cheema, H.A.; Shahid, A.; Ehsan, M.; Ayyan, M. The misuse of funnel plots in meta-analyses of proportions: Are they really useful? Clin. Kidney J. 2022, 15, 1209–1210. [Google Scholar] [CrossRef] [PubMed]
  34. Hunter, J.P.; Saratzis, A.; Sutton, A.J.; Boucher, R.H.; Sayers, R.D.; Bown, M.J. In meta-analyses of proportion studies, funnel plots were found to be an inaccurate method of assessing publication bias. J. Clin. Epidemiol. 2014, 67, 897–903. [Google Scholar] [CrossRef] [PubMed]
  35. Furuya-Kanamori, L.; Barendregt, J.J.; Doi, S.A. A new improved graphical and quantitative method for detecting bias in meta-analysis. Int. J. Evid.-Based Healthc. 2018, 16, 195–203. [Google Scholar] [CrossRef] [PubMed]
  36. Del Giorno, R.; Quarenghi, M.; Stefanelli, K.; Capelli, S.; Giagulli, A.; Quarleri, L.; Stehrenberger, D.; Ossola, N.; Monotti, R.; Gabutti, L. Nutritional Risk Screening and Body Composition in COVID-19 Patients Hospitalized in an Internal Medicine Ward. Int. J. Gen. Med. 2020, 13, 1643–1651. [Google Scholar] [CrossRef] [PubMed]
  37. Larrazabal, R.B., Jr.; Chiu, H.H.C.; Palileo-Villanueva, L.A.M. Outcomes of nutritionally at-risk Coronavirus Disease 2019 (COVID 19) patients admitted in a tertiary government hospital: A follow-up study of the MalnutriCoV study. Clin. Nutr. ESPEN 2021, 43, 239–244. [Google Scholar] [CrossRef]
  38. Martin–Martinez, A.; Ortega, O.; Viñas, P.; Arreola, V.; Nascimento, W.; Costa, A.; Riera, S.A.; Alarcón, C.; Clavé, P. COVID-19 is associated with oropharyngeal dysphagia and malnutrition in hospitalized patients during the spring 2020 wave of the pandemic. Clin. Nutr. 2021, 41, 2996–3006. [Google Scholar] [CrossRef]
  39. Mendes, A.; Serratrice, C.; Herrmann, F.R.; Gold, G.; Graf, C.E.; Zekry, D.; Genton, L. Nutritional risk at hospital admission is associated with prolonged length of hospital stay in old patients with COVID-19. Clin. Nutr. 2021, 41, 3085–3088. [Google Scholar] [CrossRef]
  40. Voelkle, M.; Gregoriano, C.; Neyer, P.; Koch, D.; Kutz, A.; Bernasconi, L.; Conen, A.; Mueller, B.; Schuetz, P. Prevalence of Micronutrient Deficiencies in Patients Hospitalized with COVID-19: An Observational Cohort Study. Nutrients 2022, 14, 1862. [Google Scholar] [CrossRef]
  41. Youssef, N.; Elbadry, M.; Al Shafie, A.; Abdalazeem, A.; Hasan, S.; Tahoon, M.; Omran, D.; El Kassas, M.; Msc, A.A.S.; Msc, A.A.; et al. Nutritional status associated with clinical outcomes among patients hospitalized with COVID-19: A multicenter prospective study in Egypt. Nurs. Health Sci. 2022, 24, 204–213. [Google Scholar] [CrossRef]
  42. Zhao, X.; Li, Y.; Ge, Y.; Shi, Y.; Lv, P.; Zhang, J.; Fu, G.; Zhou, Y.; Jiang, K.; Lin, N.; et al. Evaluation of Nutrition Risk and Its Association With Mortality Risk in Severely and Critically Ill COVID-19 Patients. JPEN J. Parenter. Enter. Nutr. 2021, 45, 32–42. [Google Scholar] [CrossRef]
  43. Zhang, K.; Qin, W.; Zheng, Y.; Pang, J.; Zhong, N.; Fei, J.; Li, Y.; Jian, X.; Hou, X.; Hu, Z.; et al. Malnutrition Contributes to Low Lymphocyte Count in Early-Stage Coronavirus Disease-2019. Front. Nutr. 2021, 8, 739216. [Google Scholar] [CrossRef] [PubMed]
  44. Liu, G.; Zhang, S.; Mao, Z.; Wang, W.; Hu, H. Clinical significance of nutritional risk screening for older adult patients with COVID-19. Eur. J. Clin. Nutr. 2020, 74, 876–883. [Google Scholar] [CrossRef] [PubMed]
  45. Liu, A.; Cong, J.; Wang, Q.; Mei, Y.; Peng, Y.; Zhou, M.; Zhu, W.; Chen, X.; Guan, W.; He, P. Risk of Malnutrition Is Common in Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A Cross-sectional Study. J. Nutr. 2021, 151, 1591–1596. [Google Scholar] [CrossRef] [PubMed]
  46. Pimentel, R.F.W.; Moraes, G.C.D.; Barcelos, S.G.C.; Figueiredo, P.C.M.D.; Das Merces, M.C. Evaluation of Nutritional Risk and Prevalence of Obesity in Patients with COVID-19 in A Reference Hospital in Salvador, Bahia, Brazil: A Cross-Sectional Study. Int. J. Nutrol. 2021, 14, 11–15. [Google Scholar] [CrossRef]
  47. Pironi, L.; Sasdelli, A.S.; Ravaioli, F.; Baracco, B.; Battaiola, C.; Bocedi, G.; Brodosi, L.; Leoni, L.; Mari, G.A.; Musio, A. Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease. Clin Nutr 2021, 40, 1330–1337. [Google Scholar] [CrossRef]
  48. Shabanpur, M.; Pourmahmoudi, A.; Nicolau, J.; Veronese, N.; Roustaei, N.; Jahromi, A.J.; Hosseinikia, M. The importance of nutritional status on clinical outcomes among both ICU and Non-ICU patients with COVID-19. Clin. Nutr. ESPEN 2022, 49, 225–231. [Google Scholar] [CrossRef]
  49. Alikiaii, B.; Heidari, Z.; Fazeli, A.; Rahimi Varposhti, M.; Moradi Farsani, D.; Fattahpour, S.; Rafiee, S.; Bagherniya, M. Evaluation of the effectiveness of the Nutritional Risk Screening System 2002 (NRS-2002) in COVID-19 patients admitted to the intensive care unit. Int. J. Clin. Pr. 2021, 75, e14934. [Google Scholar] [CrossRef]
  50. Czapla, M.; Juárez-Vela, R.; Gea-Caballero, V.; Zieliński, S.; Zielińska, M. The Association between Nutritional Status and In-Hospital Mortality of COVID-19 in Critically-Ill Patients in the ICU. Nutrients 2021, 13, 3302. [Google Scholar] [CrossRef]
  51. Martins, P.M.; Gomes, T.L.N.; Franco, E.P.; Vieira, L.L.; Pimentel, G.D. High neutrophil-to-lymphocyte ratio at intensive care unit admission is associated with nutrition risk in patients with COVID-19. J. Parenter. Enter. Nutr. 2022, 46, 1441–1448. [Google Scholar] [CrossRef]
  52. Wu, S.; Lou, J.; Xu, P.; Luo, R.; Li, L. Early enteral nutrition improves the outcome of critically ill patients with COVID-19: A retrospective study. Asia Pac. J. Clin. Nutr. 2021, 30, 192–198. [Google Scholar] [CrossRef]
  53. Thomas, S.; Alexander, C.; Cassady, B.A. Nutrition risk prevalence and nutrition care recommendations for hospitalized and critically-ill patients with COVID-19. Clin. Nutr. ESPEN 2021, 44, 38–49. [Google Scholar] [CrossRef] [PubMed]
  54. Hawryłkowicz, V.; Lietz-Kijak, D.; Kaźmierczak-Siedlecka, K.; Sołek-Pastuszka, J.; Stachowska, L.; Folwarski, M.; Parczewski, M.; Stachowska, E. Patient Nutrition and Probiotic Therapy in COVID-19: What Do We Know in 2021? Nutrients 2021, 13, 3385. [Google Scholar] [CrossRef] [PubMed]
  55. Vong, T.; Yanek, L.R.; Wang, L.; Yu, H.; Fan, C.; Zhou, E.; Oh, S.J.; Szvarca, D.; Kim, A.; Potter, J.J.; et al. Malnutrition Increases Hospital Length of Stay and Mortality among Adult Inpatients with COVID-19. Nutrients 2022, 14, 1310. [Google Scholar] [CrossRef]
  56. Mohammadi, P.; Varpaei, H.A.; Mohammadi, M.; Rahimi, M.; Orandi, A. Evaluation of the Relationship between Nutritional Status of COVID-19 Patients Admitted to the ICU and Patients’ Prognosis: A Cohort Study. J. Nutr. Metab. 2022, 2022, 5016649. [Google Scholar] [CrossRef]
  57. Kang, M.C.; Kim, J.H.; Ryu, S.-W.; Moon, J.Y.; Park, J.H.; Park, J.K.; Baik, H.-W.; Seo, J.-M.; Son, M.-W.; Song, G.A.; et al. Prevalence of malnutrition in hospitalized patients: A multicenter cross-sectional study. J. Korean Med. Sci. 2018, 33, e10. [Google Scholar] [CrossRef]
  58. van der Meij, B.S.; Ligthart-Melis, G.C.; de van der Schueren, M.A. Malnutrition in patients with COVID-19: Assessment and consequences. Curr. Opin. Clin. Nutr. Metab. Care 2021, 24, 543–554. [Google Scholar] [CrossRef]
  59. Sulli, A.; Gotelli, E.; Casabella, A.; Paolino, S.; Pizzorni, C.; Alessandri, E.; Grosso, M.; Ferone, D.; Smith, V.; Cutolo, M. Vitamin D and lung outcomes in elderly COVID-19 patients. Nutrients 2021, 13, 717. [Google Scholar] [CrossRef]
  60. Ali, A.M.; Kunugi, H. Approaches to nutritional screening in patients with Coronavirus Disease 2019 (COVID-19). Int. J. Environ. Res. Public Health 2021, 18, 2772. [Google Scholar] [CrossRef]
  61. Kroc, Ł.; Fife, E.; Piechocka-Wochniak, E.; Sołtysik, B.; Kostka, T. Comparison of nutrition risk screening 2002 and subjective global assessment form as short nutrition assessment tools in older hospitalized adults. Nutrients 2021, 13, 225. [Google Scholar] [CrossRef]
  62. Paulsen, M.M.; Hagen, M.L.L.; Frøyen, M.H.; Foss-Pedersen, R.J.; Bergsager, D.; Tangvik, R.J.; Andersen, L.F. A dietary assessment app for hospitalized patients at nutritional risk: Development and evaluation of the MyFood app. JMIR Mhealth Uhealth 2018, 6, e9953. [Google Scholar] [CrossRef]
  63. de Bruin, J.S.; Schuh, C.; Seeling, W.; Luger, E.; Gall, M.; Hütterer, E.; Kornek, G.; Ludvik, B.; Hoppichler, F.; Schindler, K. Assessing the feasibility of a mobile health-supported clinical decision support system for nutritional triage in oncology outpatients using Arden Syntax. Artif. Intell. Med. 2018, 92, 34–42. [Google Scholar] [CrossRef]
  64. Barazzoni, R.; Bischoff, S.C.; Breda, J.; Wickramasinghe, K.; Krznaric, Z.; Nitzan, D.; Pirlich, M.; Singer, P. ESPEN Expert Statements and Practical Guidance for Nutritional Management of Individuals with SARS-CoV-2 Infection; Elsevier: Amsterdam, The Netherlands, 2020; Volume 39, pp. 1631–1638. [Google Scholar]
  65. Caccialanza, R.; Laviano, A.; Lobascio, F.; Montagna, E.; Bruno, R.; Ludovisi, S.; Corsico, A.G.; Di Sabatino, A.; Belliato, M.; Calvi, M.; et al. Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol. Nutrition 2020, 74, 110835. [Google Scholar] [CrossRef] [PubMed]
  66. Martindale, R.; Patel, J.J.; Taylor, B.; Arabi, Y.M.; Warren, M.; McClave, S.A. Nutrition therapy in critically ill patients with coronavirus disease 2019. J. Parenter. Enter. Nutr. 2020, 44, 1174–1184. [Google Scholar] [CrossRef] [PubMed]
  67. Terblanche, E.; Hills, J.; Russell, E.; Lewis, R.; Rose, L. Dietetic-Led Nutrition Interventions in Patients with COVID-19 during Intensive Care and Ward-Based Rehabilitation: A Single-Center Observational Study. Nutrients 2022, 14, 1062. [Google Scholar] [CrossRef] [PubMed]
  68. Volkert, D.; Beck, A.M.; Cederholm, T.; Cruz-Jentoft, A.; Goisser, S.; Hooper, L.; Kiesswetter, E.; Maggio, M.; Raynaud-Simon, A.; Sieber, C.C.; et al. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin. Nutr. 2019, 38, 10–47. [Google Scholar] [CrossRef] [Green Version]
  69. Thomson, K.H.; Rice, S.; Arisa, O.; Johnson, E.; Tanner, L.; Marshall, C.; Sotire, T.; Richmond, C.; O’Keefe, H.; Mohammed, W.; et al. Effectiveness and cost-effectiveness of oral nutritional supplements in frail older people who are malnourished or at risk of malnutrition: A systematic review and meta-analysis. Lancet Healthy Longev. 2022, 3, e654–e666. [Google Scholar] [CrossRef]
  70. Da Porto, A.; Tascini, C.; Peghin, M.; Sozio, E.; Colussi, G.; Casarsa, V.; Bulfone, L.; Graziano, E.; De Carlo, C.; Catena, C.; et al. Prognostic Role of Malnutrition Diagnosed by Bioelectrical Impedance Vector Analysis in Older Adults Hospitalized with COVID-19 Pneumonia: A Prospective Study. Nutrients 2021, 13, 4085. [Google Scholar] [CrossRef]
  71. Wierdsma, N.J.; Kruizenga, H.M.; Konings, L.A.; Krebbers, D.; Jorissen, J.R.; Joosten, M.I.; van Aken, L.H.; Tan, F.M.; van Bodegraven, A.A.; Soeters, M.R.; et al. Poor nutritional status, risk of sarcopenia and nutrition related complaints are prevalent in COVID-19 patients during and after hospital admission. Clin. Nutr. ESPEN 2021, 43, 369–376. [Google Scholar] [CrossRef]
  72. Zhou, J.; Ma, Y.; Liu, Y.; Xiang, Y.; Tao, C.; Yu, H.; Huang, J. A Correlation Analysis between the Nutritional Status and Prognosis of COVID-19 Patients. J. Nutr. Health Aging 2021, 25, 84–93. [Google Scholar] [CrossRef]
  73. Song, F.; Ma, H.; Wang, S.; Qin, T.; Xu, Q.; Yuan, H.; Li, F.; Wang, Z.; Liao, Y.; Tan, X.; et al. Nutritional screening based on objective indices at admission predicts in-hospital mortality in patients with COVID-19. Nutr. J. 2021, 20, 46. [Google Scholar] [CrossRef]
  74. You, Y.; Chen, M.; Chen, X.; Yu, W. Diaphragm thickness on computed tomography for nutritional assessment and hospital stay prediction in critical COVID-19. Asia Pac. J. Clin. Nutr. 2022, 31, 33–40. [Google Scholar] [CrossRef] [PubMed]
  75. Recinella, G.; Marasco, G.; Serafini, G.; Maestri, L.; Bianchi, G.; Forti, P.; Zoli, M. Prognostic role of nutritional status in elderly patients hospitalized for COVID-19: A monocentric study. Aging Clin. Exp. Res. 2020, 32, 2695–2701. [Google Scholar] [CrossRef] [PubMed]
  76. Otero, J.A.; Figuero, L.S.B.; Mattin, M.G.; Martin, I.U.; Morais, P.C.; Olmedo, L.C.; Galiana, L.I.; Gutierrez, C.D.; Gomez, J.C.; Gudino, L.C.; et al. The nutritional status of the elderly patient infected with COVID-19: The forgotten risk factor? Figshare 2021, 37, 549–554. [Google Scholar] [CrossRef]
  77. McGovern, J.; Al-Azzawi, Y.; Kemp, O.; Moffitt, P.; Richards, C.; Dolan, R.D.; Laird, B.J.; McMillan, D.C.; Maguire, D. The relationship between frailty, nutritional status, co-morbidity, CT-body composition and systemic inflammation in patients with COVID-19. J. Transl. Med. 2022, 20, 98. [Google Scholar] [CrossRef] [PubMed]
  78. Cui, N.; Tong, H.; Li, Y.; Ge, Y.; Shi, Y.; Lv, P.; Zhao, X.; Zhang, J.; Fu, G.; Zhou, Y.; et al. Role of Prealbumin in Predicting the Prognosis of Severely and Critically Ill COVID-19 Patients. Am. J. Trop. Med. Hyg. 2021, 105, 718–726. [Google Scholar] [CrossRef]
  79. Fernandes, A.L.; Reis, B.Z.; Murai, I.H.; Pereira, R.M.R. Prognostic Nutritional Index and Oxygen Therapy Requirement Associated With Longer Hospital Length of Stay in Patients With Moderate to Severe COVID-19: Multicenter Prospective Cohort Analyses. Front. Nutr. 2022, 9, 802562. [Google Scholar] [CrossRef]
  80. Liu, H.; Zhou, L.; Wang, H.; Wang, X.; Qu, G.; Cai, J.; Zhang, H. Malnutrition is associated with hyperinflammation and immunosuppression in COVID-19 patients: A prospective observational study. Nutr. Clin. Pract. 2021, 36, 863–871. [Google Scholar] [CrossRef]
  81. Allard, L.; Ouedraogo, E.; Molleville, J.; Bihan, H.; Giroux-Leprieur, B.; Sutton, A.; Baudry, C.; Josse, C.; Didier, M.; Deutsch, D.; et al. Malnutrition: Percentage and Association with Prognosis in Patients Hospitalized for Coronavirus Disease 2019. Nutrients 2020, 12, 3679. [Google Scholar] [CrossRef]
  82. Wei, C.; Liu, Y.; Li, Y.; Zhang, Y.; Zhong, M.; Meng, X. Evaluation of the nutritional status in patients with COVID-19. J. Clin. Biochem. Nutr. 2020, 67, 116–121. [Google Scholar] [CrossRef]
  83. Rouget, A.; Vardon-Bounes, F.; Lorber, P.; Vavasseur, A.; Marion, O.; Marcheix, B.; Lairez, O.; Balardy, L.; Fourcade, O.; Conil, J.-M. Prevalence of malnutrition in coronavirus disease 19: The NUTRICOV study. Br. J. Nutr. 2021, 126, 1296–1303. [Google Scholar] [CrossRef]
  84. Vaillant, M.-F.; Agier, L.; Martineau, C.; Philipponneau, M.; Romand, D.; Masdoua, V.; Behar, M.; Nesseler, C.; Achamrah, N.; Laubé, V. Food intake and weight loss of surviving inpatients in the course of COVID-19 infection: A longitudinal study of the multicenter NutriCoviD30 cohort. Nutrition 2022, 93, 111433. [Google Scholar] [CrossRef] [PubMed]
  85. Thiam, C.N.; Mathavan, S.; Abdullah, A.; Chong, E.G.M. Malnutrition among patients admitted to the subacute geriatric ward during the COVID-19 pandemic era: A cross-sectional study in a tertiary hospital in Malaysia. Med. J. Malays. 2022, 77, 313–319. [Google Scholar]
  86. Farina, N.; Nordbeck, S.; Montgomery, M.; Cordwin, L.; Blair, F.; Cherry-Bukowiec, J.; Kraft, M.D.; Pleva, M.R.; Raymond, E. Early Enteral Nutrition in Mechanically Ventilated Patients With COVID-19 Infection. Nutr. Clin. Pract. 2021, 36, 440–448. [Google Scholar] [CrossRef] [PubMed]
  87. Fiorindi, C.; Campani, F.; Rasero, L.; Campani, C.; Livi, L.; Giovannoni, L.; Amato, C.; Giudici, F.; Bartoloni, A.; Fattirolli, F.; et al. Prevalence of nutritional risk and malnutrition during and after hospitalization for COVID-19 infection: Preliminary results of a single-centre experience. Clin. Nutr. ESPEN 2021, 45, 351–355. [Google Scholar] [CrossRef] [PubMed]
  88. Stefano, M.; Andrea, B.; Daniela, C.; Emanuela, M.; Lorena, P.; Daniela, D.; Sökeland, F.; Azzolini, E.; Beatrice, M. Malnutrition risk as a negative prognostic factor in COVID-19 patients. Clin. Nutr. ESPEN 2021, 45, 369–373. [Google Scholar] [CrossRef]
  89. Ansu, V.; Papoutsakis, C.; Gletsu-Miller, N.; Spence, L.A.; Kelley, K.; Woodcock, L.; Wallace, T.C.; Steiber, A. Nutrition care practice patterns for patients with COVID-19—A preliminary report. J. Parenter. Enter. Nutr. 2021, 45, 1774–1778. [Google Scholar] [CrossRef]
  90. Nicolau, J.; Ayala, L.; Sanchis, P.; Olivares, J.; Dotres, K.; Soler, A.-G.; Rodriguez, I.; Gomez, L.-A.; Masmiquel, L. Influence of nutritional status on clinical outcomes among hospitalized patients with COVID-19. Clin. Nutr. ESPEN 2021, 43, 223–229. [Google Scholar] [CrossRef]
  91. Rives-Lange, C.; Zimmer, A.; Merazka, A.; Carette, C.; Martins-Bexinga, A.; Hauw-Berlemont, C.; Guerot, E.; Jannot, A.S.; Diehl, J.L.; Czernichow, S.; et al. Evolution of the nutritional status of COVID-19 critically-ill patients: A prospective observational study from ICU admission to three months after ICU discharge. Clin. Nutr. 2021, 41, 3026–3031. [Google Scholar] [CrossRef]
  92. Shahbazi, S.; Hajimohammadebrahim-Ketabforoush, M.; Shariatpanahi, M.V.; Shahbazi, E.; Shariatpanahi, Z.V. The validity of the global leadership initiative on malnutrition criteria for diagnosing malnutrition in critically ill patients with COVID-19: A prospective cohort study. Clin. Nutr. ESPEN 2021, 43, 377–382. [Google Scholar] [CrossRef]
  93. Gómez-Uranga, A.; Guzmán-Martínez, J.; Esteve-Atiénzar, P.J.; Wikman-Jorgensen, P.; Núñez-Cruz, J.M.; Espinosa-Del-Barrio, L.; Hernández-Isasi, I.; Pomares-Gómez, F.J.; Perelló-Camacho, E.; Fernández-García, N.; et al. Nutritional and Functional Impact of Acute SARS-CoV-2 Infection in Hospitalized Patients. J. Clin. Med. 2022, 11, 2424. [Google Scholar] [CrossRef]
  94. Martinuzzi, A.L.N.; Manzanares, W.; Quesada, E.; Reberendo, M.J.; Baccaro, F.; Aversa, I.; Kecskes, C.E.; Magnífico, L.; González, V.; Bolzico, D.; et al. Nutritional risk and clinical outcomes in critically ill adult patients with COVID-19. Nutr. Hosp. 2021, 38, 1119–1125. [Google Scholar] [CrossRef] [PubMed]
  95. Vahdat Shariatpanahi, Z.; Vahdat Shariatpanahi, M.; Shahbazi, E.; Shahbazi, S. Refeeding Syndrome and Its Related Factors in Critically Ill Coronavirus Disease 2019 Patients: A Prospective Cohort Study. Front. Nutr. 2022, 9, 830457. [Google Scholar] [CrossRef] [PubMed]
  96. Chadli, A.; Haraj, N.E.; El Aziz, S.; Laidi, S.; Mounir, A.; Bensbaa, S.; Mjabber, A.; Barrou, L.; El Kettani El Hamidi, C.; Nsiri, A.; et al. COVID-19: Patient care after discharge from the Intensive Care Unit. Int. J. Clin. Pract. 2021, 75, e14270. [Google Scholar] [CrossRef]
  97. Leoni, M.L.G.; Moschini, E.; Beretta, M.; Zanello, M.; Nolli, M. The modified NUTRIC score (mNUTRIC) is associated with increased 28-day mortality in critically ill COVID-19 patients: Internal validation of a prediction model. Clin. Nutr. ESPEN 2022, 48, 202–209. [Google Scholar] [CrossRef] [PubMed]
  98. Zhang, P.; He, Z.; Yu, G.; Peng, D.; Feng, Y.; Ling, J.; Wang, Y.; Li, S.; Bian, Y. The modified NUTRIC score can be used for nutritional risk assessment as well as prognosis prediction in critically ill COVID-19 patients. Clin. Nutr. 2021, 40, 534–541. [Google Scholar] [CrossRef] [PubMed]
  99. Li, G.; Zhou, C.-L.; Ba, Y.-M.; Wang, Y.-M.; Song, B.; Cheng, X.-B.; Dong, Q.-F.; Wang, L.-L.; You, S.-S. Nutritional risk and therapy for severe and critical COVID-19 patients: A multicenter retrospective observational study. Clin. Nutr. 2021, 40, 2154–2161. [Google Scholar] [CrossRef] [PubMed]
  100. Cuerda, C.; Sánchez López, I.; Gil Martínez, C.; Merino Viveros, M.; Velasco, C.; Cevallos Peñafiel, V.; Maíz Jiménez, M.; Gonzalo, I.; González-Sánchez, V.; Ramos Carrasco, A.; et al. Impact of COVID-19 in nutritional and functional status of survivors admitted in intensive care units during the first outbreak. Preliminary results of the NUTRICOVID study. Clin. Nutr. 2021, 41, 2934–2939. [Google Scholar] [CrossRef]
Nutrients 14 05267 g001 550
Figure 1. Flow chart of literature review and study selection.
Figure 1. Flow chart of literature review and study selection.
Nutrients 14 05267 g001
Nutrients 14 05267 g002 550
Figure 2. Quality assessment by Newcastle–Ottawa Scales (Green indicates score, red indicates no score) [36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52]. 1 Non-respondents: one point is granted if the individual study included data from all patients during the study period, or if they specified the number/proportion of patients excluded from the analysis. 2 Ascertainment of exposure: one point is granted if COVID-19 diagnosis/ascertainment method is clearly described in the individual study. 3 Control for important factor: In this meta-analysis, the primary stratification factor is the source of patients (ICU/general ward). One point is granted if the individual study specified the patient source, or when the study population included patients from mixed sources, specified the prevalence of malnutrition in each subgroup. 4 Control for additional factor: one point is granted if the individual study further presented subgroup analyses by sex, age groups, COVID-19 severity, etc. 5 Assessment of outcome (validated tool): All studies included used NRS-2002 to evaluate the nutritional status of the patients, therefore one point is granted for all. 6 Assessment of outcome (data collection): one point is granted if the individual study clearly described the protocol of NRS-2002 evaluation, include but not limited to the measurement of height, weight, and food intake by experienced nutritionists.
Figure 2. Quality assessment by Newcastle–Ottawa Scales (Green indicates score, red indicates no score) [36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52]. 1 Non-respondents: one point is granted if the individual study included data from all patients during the study period, or if they specified the number/proportion of patients excluded from the analysis. 2 Ascertainment of exposure: one point is granted if COVID-19 diagnosis/ascertainment method is clearly described in the individual study. 3 Control for important factor: In this meta-analysis, the primary stratification factor is the source of patients (ICU/general ward). One point is granted if the individual study specified the patient source, or when the study population included patients from mixed sources, specified the prevalence of malnutrition in each subgroup. 4 Control for additional factor: one point is granted if the individual study further presented subgroup analyses by sex, age groups, COVID-19 severity, etc. 5 Assessment of outcome (validated tool): All studies included used NRS-2002 to evaluate the nutritional status of the patients, therefore one point is granted for all. 6 Assessment of outcome (data collection): one point is granted if the individual study clearly described the protocol of NRS-2002 evaluation, include but not limited to the measurement of height, weight, and food intake by experienced nutritionists.
Nutrients 14 05267 g002
Nutrients 14 05267 g003 550
Figure 3. The pooled prevalence of malnutrition in COVID-19 patients [36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52].
Figure 3. The pooled prevalence of malnutrition in COVID-19 patients [36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52].
Nutrients 14 05267 g003
Nutrients 14 05267 g004 550
Figure 4. Subgroup analysis of the pooled prevalence of malnutrition in COVID-19 patients by medium/mean age [36,38,39,40,41,43,44,45,46,49,51,52].
Figure 4. Subgroup analysis of the pooled prevalence of malnutrition in COVID-19 patients by medium/mean age [36,38,39,40,41,43,44,45,46,49,51,52].
Nutrients 14 05267 g004
Nutrients 14 05267 g005 550
Figure 5. Subgroup Analysis of the Prevalence of Malnutrition in COVID-19 Patients by World Bank country classifications by income level [36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52]. High-income economies: Switzerland, Spain, Italy, and Poland; Upper-middle-income economies: China and Brazil; Lower-middle-income economies: Philippines, Egypt, and Iran.
Figure 5. Subgroup Analysis of the Prevalence of Malnutrition in COVID-19 Patients by World Bank country classifications by income level [36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52]. High-income economies: Switzerland, Spain, Italy, and Poland; Upper-middle-income economies: China and Brazil; Lower-middle-income economies: Philippines, Egypt, and Iran.
Nutrients 14 05267 g005
Table
Table 1. Study characteristics of hospitalized COVID-19 patients assessed by Nutritional Risk Score-2002.
Table 1. Study characteristics of hospitalized COVID-19 patients assessed by Nutritional Risk Score-2002.
AuthorCountryTime FrameSample SizeAge 1SexCOVID-19 ConfirmationTiming of AssessmentSpecific Time of EvaluationOutcome 2Prevalence 3
General Ward
Del Giorno et al. (2020) [36]Switzerland2020/39064.5 ± 13.7Male (67.8%)PCR 4/CT 5At admissionthe first 24 h of admissionMalnutrition risk (Y/N)92.0%
Larrazabal et al. (2021) [37]Philippines2020/7/15–2020/9/15355NRNRRT-PCR 6At admissionNR 7Malnutrition risk (low/moderate/high)37.7% low; 47.3% moderate; 14.9% high risk
Martin–Martinez et al. (2021) [38]Spain2020/4/14–2020/7/3020569.3 ± 17.5Male (47.8%)PCRAt admissionNRMalnutrition risk (Y/N)88.7%
Mendes et al. (2021) [39]Switzerland2020/3/13–2020/5/1724586.1 ± 6.4 Male (42%)RT-PCRAt admissionNRMalnutrition risk (no/at risk/high risk)17.6% no risk; 32.2% at risk; 50.2% high risk
Voelkle et al. (2022) [40]Switzerland2020/3/17–2020/4/305767.0 (60.0, 74.2)Male (60%)RT-PCRAt admissionNRMalnutrition risk (Y/N)19.0%
Youssef et al. (2022) [41]Egypt2020/7–2020/1212152.4 ± 10.5Male (84.3%)NRAt admissionon day 1 of admission Malnutrition risk (Mild–moderate/Severe)94.9% Mild–moderate; 5.1% Severe
Zhao et al. (2021) [42]China2020/1/29–2020/2/19371NRNRNRAt admissionon the first day of hospitalizationMalnutrition risk (no/low/high)8% no risk; 76% low; 16% high risk
Zhang et al. (2021) [43]China2020/2/6-2020/3/2010165.3 ± 13Male (59.4%)NRAt admissionon the first day of hospitalizationMalnutrition risk(Y/N)40.5%
Liu et al. (2020) [44]China2020/1/28–2020/3/2814171.7 ± 5.9Male (48.2%)RT-PCR/CTDuring hospitaliza-tionNRMalnutrition risk (Y/N)85.1%
Liu et al. (2021) [45]China2020/1/29–2020/3/1576060 (46, 74) Male (50%)RT-PCR/CTDuring hospitaliza-tionNRMalnutrition risk (Y/N)82.6%
Pimentel et al. (2021) [46]BrazilNR4145.7 ± 12.4Male (61.0%)RT-PCRDuring hospitaliza-tionNRMalnutrition risk (low/high)22.0% low risk; 78.0% high risk
Pironi et al. (2021) [47]Italy2020/4162NRNRNRDuring hospitaliza-tiona one-day clinical auditMalnutrition risk (Y/N)67.3%
Shabanpur et al. (2022) [48]Iran2021/5–2021/7330NRNRNRDuring hospitaliza-tionin a 6-week periodMalnutrition (risk/moderate/severe)4% at risk; 69% moderate; 27% severe risk
ICU
Alikiaii et al. (2021) [49]Iran2021/1/17358.9 ± 18.8Male (63%)RT-PCRDuring hospitaliza-tionNRMalnutrition risk (low/moderate/high)17.8% low; 69.9% moderate; 12.3% high risk
Czapla et al. (2021) [50]Poland2020/9–2021/6286NRMale (67.8%)RT-PCRAt admissionat the time of admission to ICU 8Malnutrition risk(Y/N)90.2%
Martins et al. (2022) [51]Brazil2020/3–2020/107356Male (63%)PCRAt admissionthe first 48 h of admission to the ICUMalnutrition risk(Y/N)85.0%
Pironi et al. (2021) [47]Italy2020/4106NRNRNRDuring hospitaliza-tiona one-day clinical auditMalnutrition risk(Y/N)92.5%
Shabanpur et al. (2022) [48]Iran2021/5–2021/770NRNRNRDuring hospitaliza-tionin a 6-week periodMalnutrition (risk/moderate/severe)0% at risk; 20% moderate; 80% severe risk
Wu et al. (2021) [52]China2020/1/15–2020/2/292774.9 ± 10.5 Male (66.7%)NRDuring hospitaliza-tionon the seventh day of admissionMalnutrition risk (potential/ high)3.7% potential risk; 96.3% high risk
1 Data are presented as mean ± SD or median (IQR) unless otherwise specified. 2 NRS-2002 score ≥ 3 is considered at risk of malnutrition (NRS 3–4: moderate risk of malnutrition; NRS ≥ 5: severe risk of malnutrition). 3 Prevalence was extracted from the original results of each publication. In subsequent analyses, unified prevalence of risk of malnutrition was calculated as the proportion of patients with NRS-2002 score ≥ 3. 4 PCR, polymerase chain reaction. 5 CT, computed tomography. 6 RT-PCR, reverse transcription polymerase chain reaction. 7 NR, not reported. 8 ICU, intensive care unit.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Feng, X.; Liu, Z.; He, X.; Wang, X.; Yuan, C.; Huang, L.; Song, R.; Wu, Y. Risk of Malnutrition in Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis. Nutrients 2022, 14, 5267. https://doi.org/10.3390/nu14245267

AMA Style

Feng X, Liu Z, He X, Wang X, Yuan C, Huang L, Song R, Wu Y. Risk of Malnutrition in Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis. Nutrients. 2022; 14(24):5267. https://doi.org/10.3390/nu14245267

Chicago/Turabian Style

Feng, Xiaoru, Zeqi Liu, Xiaotong He, Xibiao Wang, Changzheng Yuan, Liyan Huang, Rui Song, and You Wu. 2022. "Risk of Malnutrition in Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis" Nutrients 14, no. 24: 5267. https://doi.org/10.3390/nu14245267

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop